LOXO LARO 25 mg Pill - white capsule/oblong, 18mm
Generic Name: larotrectinib
Pill with imprint LOXO LARO 25 mg is White, Capsule/Oblong and has been identified as Vitrakvi 25 mg. It is supplied by Loxo Oncology, Inc.
Vitrakvi is used in the treatment of Solid Tumors and belongs to the drug class multikinase inhibitors. Vitrakvi 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LOXO LARO 25 mg
Vitrakvi
- Generic Name
- larotrectinib
- Imprint
- LOXO LARO 25 mg
- Strength
- 25 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Loxo Oncology, Inc.
- National Drug Code (NDC)
- 71777-0390 (Discontinued)
More about Vitrakvi (larotrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Imprints, shape & color data
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
